eol
EOL: Energy Trading Software - Priced for Perfection in an Imperfect World
Updated 8 Oct 2025
STRONG SELL rating with 84% downside to $2.20 fair value. EBITDA margins compressing from 26.4% peak as competition intensifies.
View noteequity-research
emr
EMR: Gold Mining Transformer - Digging Deep, Priced Sky High
Updated 8 Oct 2025
Quality gold producer with US$1,075/oz AISC trading at A$4.11 vs A$2.71 fair value. Strong operations, excessive valuation, 34% overvalued.
View noteeml
EML: Payment Processor - Transformation Time, Discount Divine
Updated 8 Oct 2025
Payment processor trading at 42% discount to peers. Fair value $1.60 vs current $1.07. EBITDA margins recovering from 16.5% toward 26% through transformation programme.
View noteehl
EHL: Mining Equipment Rental - Deep Value Digging for Gold
Updated 8 Oct 2025
BUY rating with $1.83 fair value vs $0.93 current price. 38.3% EBITDA margins, 18.5% market share, trading at 63% discount to peers despite superior metrics.
View noteegh
EGH: Seniors' Rental Leader - All-Age Ambitions Meet Execution Reality
Updated 8 Oct 2025
HOLD rating with $0.56 fair value vs $0.57 current price. Market leader in seniors' rental (18% share, 98% occupancy) executing risky all-age expansion. 35% execution failure probability creates binary outcomes.
View noteedv
EDV: Liquor & Gaming Giant - Regulatory Moats Meet Market Malaise
Updated 8 Oct 2025
Market leader trading at 48% discount to peers despite regulatory moats. Fair value $5.02 vs current $4.18 with 20% upside potential.
View noteedu
EDU: Education Provider - Regulatory Roulette with Remarkable Returns
Updated 8 Oct 2025
Fair value $0.65 vs current $0.515. 30% EBITDA margins, 46% ROIC, but 89% international student dependency creates binary regulatory risk.
View noteecf
ECF: Office REIT Specialist - Discount Opportunity Amid Management Transition
Updated 8 Oct 2025
ECF trades at 31% discount to $1.02 fair value with 10.7% yield, 96.3% occupancy vs 94% peers, facing external management transition risks
View noteebr
EBR: Leadless CRT Pioneer - Innovation's Dead End
Updated 8 Oct 2025
Pre-commercial cardiac device company with negative $(0.24) fair value. 77% revenue CAGR offset by permanent -178% EBITDA margins. 75% probability of value destruction versus 25% strategic acquisition hope.
View noteebo
EBO: Healthcare Distribution Giant - Wholesale Disruption Looms Large
Updated 8 Oct 2025
SELL rating with fair value $18.62 vs current $30.24. Healthcare distribution leader faces margin compression and direct distribution threats.
View notedxs
DXS: Office REIT Giant - Hybrid Working's Permanent Hangover
Updated 8 Oct 2025
SELL rating with fair value $4.71 vs current $7.42. Office REIT facing structural headwinds from hybrid working, 64% downside risk.
View notedxi
DXI: Industrial REIT Specialist - Development Dreams Meet Reality Check
Updated 8 Oct 2025
HOLD rating with $2.39 fair value vs $2.80 current price. Exceptional 98.6% occupancy offset by development execution risks and overvaluation concerns.
View note